Author Topic: MS patients at greater risk of cardiovascular disease, study shows  (Read 85 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9841
  • MS diagnosed 1980
  • Location: Pacific Northwest

From JAMA Neurology (May 4, 2020), "Evaluating the risk of macrovascular events and mortality among people with multiple sclerosis":


https://bit.ly/3c2kcv6
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
1 Replies
162 Views
Last post July 08, 2016, 03:30:05 pm
by agate
0 Replies
118 Views
Last post April 29, 2018, 04:13:33 pm
by agate
0 Replies
46 Views
Last post February 08, 2020, 09:23:11 pm
by agate
0 Replies
45 Views
Last post May 25, 2020, 06:42:18 am
by agate
0 Replies
24 Views
Last post June 20, 2022, 09:26:16 pm
by agate